Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Moran Szwarcwort"'
Autor:
Nesrin Ghanem-Zoubi, Yafit Atiya-Nasagi, Evgeniy Stoyanov, Moran Szwarcwort, Basel Darawsha, Mical Paul, Eilat Shinar
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 5, Pp 941-946 (2024)
We evaluated Q fever prevalence in blood donors and assessed the epidemiologic features of the disease in Israel in 2021. We tested serum samples for Coxeilla burnetii phase I and II IgG using immunofluorescent assay, defining a result of >200 as ser
Externí odkaz:
https://doaj.org/article/519579dcac104fecaeaa97c1183bcbab
Autor:
Nasreen Hassoun-Kheir, Khetam Hussien, Marianne Karram, Maram Saffuri, Sally Badaan, Shani Peleg, Worood Aboelhega, Sigal Warman, Tamar Alon, Dina Pollak, Moran Szwarcwort Cohen, Mical Paul
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 12, Iss 1, Pp 1-8 (2023)
Abstract Background Carbapenem-resistant Enterobacterales (CRE) infections have a significant morbidity and mortality toll. The clinical significance and associated burden of CRE colonization rather than infection state are not frequently investigate
Externí odkaz:
https://doaj.org/article/9b87d2dadb984c0b9e838409e029a317
Autor:
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Antibodies, Vol 13, Iss 3, p 63 (2024)
Background: Previous studies showed that the fourth SARS-CoV-2 vaccine dose has a protective effect against infection, as well as against severe disease and death. This study aimed to examine whether knowledge of a high-level antibody after the third
Externí odkaz:
https://doaj.org/article/6feb34e525aa48eaa6caf2908edfa1f8
Autor:
Milena Pitashny, Balqees Kadry, Raya Shalaginov, Liat Gazit, Yaniv Zohar, Moran Szwarcwort, Yoav Stabholz, Mical Paul
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
We hypothesized that targeted NGS sequencing might have an advantage over Sanger sequencing, especially in polymicrobial infections. The study included 55 specimens from 51 patients. We compared targeted NGS to Sanger sequencing in clinical samples s
Externí odkaz:
https://doaj.org/article/664b25ef982c47039e483664c5a3f11a
Publikováno v:
Emerging Infectious Diseases, Vol 27, Iss 8, Pp 2205-2207 (2021)
Q fever infective endocarditis frequently mimics degenerative valvular disease. We tested for Coxiella burnettii antibodies in 155 patients in Israel who underwent transcatheter aortic valve implantation. Q fever infective endocarditis was diagnosed
Externí odkaz:
https://doaj.org/article/d22df1d8542344a699f911eca203cc8a
Autor:
Khetam Hussein, Yael Shachor-Meyouhas, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Jalal Tarabeia, Avi Weissman, Michal Mekel, Gila Hyams, Michael Halberthal
Publikováno v:
Rambam Maimonides Medical Journal, Vol 13, Iss 2, p e0011 (2022)
Background: With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary med
Externí odkaz:
https://doaj.org/article/142311ef807848438d121b94cb2830d4
Autor:
Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Nethanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Khetam Hussein
Publikováno v:
Vaccines, Vol 11, Iss 2, p 283 (2023)
Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after v
Externí odkaz:
https://doaj.org/article/d22a835f0ef34a94b8e2e3f98eb189bb
Autor:
Rana Swed-Tobia, Imad Kassis, Suhair Hanna, Moran Szwarcwort-Cohen, Sara Dovrat, Halima Dabaja-Younis
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 4, Pp 1129-1131 (2021)
Varicella live attenuated vaccine led to a significant reduction in morbidity and mortality from varicella zoster disease. Vaccine adverse effects are mostly mild. Immunosuppression is the main risk factor for severe varicella. Risk factors for disea
Externí odkaz:
https://doaj.org/article/c3f164ebc0034c34a84396156a737b9f
Autor:
Etty Kruzel-Davila, Barbara Mensah Sankofi, Ernestine Kubi Amos-Abanyie, Anita Ghansah, Alexander Nyarko, Seth Agyemang, Gordon A. Awandare, Moran Szwarcwort-Cohen, Anat Reiner-Benaim, Basem Hijazi, Ifeoma Ulasi, Yemi Raheem Raji, Vincent Boima, Charlotte Osafo, Victoria May Adabayeri, Michael Matekole, Timothy O. Olanrewaju, Samuel Ajayi, Manmak Mamven, Sampson Antwi, Adebowale D. Ademola, Jacob Plange-Rhule, Fatiu Arogundade, Priscilla Abena Akyaw, Cheryl A. Winkler, Babatunde L. Salako, Akinlolu Ojo, Karl Skorecki, Dwomoa Adu
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Variants in the Apolipoprotein L1 (APOL1) gene (G1-rs60910145, rs73885319, G2-rs71785313) are common in Africans and in individuals of recent African ancestry and are associated with an increased risk of non-diabetic chronic kidney disease (CKD) and
Externí odkaz:
https://doaj.org/article/9166d56358b24d75b5f9af0dafb69996
Autor:
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Ronit Leiba, Avi Weissman, Michal Mekel, Gila Hyams, Nethanel A. Horowitz, Vardit Gepstein, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1741 (2022)
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at 1, 3, 6, 9, and 12 months after receiving th
Externí odkaz:
https://doaj.org/article/e122aafc9b7b4ade9fe7b2942aa93910